Western Drug Recalls Alcohol and Bupivicaine Solution Due to Sterility Concerns
Western Drug is recalling Alcohol 4%/Bupivicaine 0.5% solution because there is a lack of assurance of sterility. The product was distributed nationwide in eight states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls are assigned a score of 4 (Severe), particularly when involving potential hospitalization or significant injury risks associated with sterility failures in injectable medications.
Plain-English summary
Western Drug Inc. is recalling three containers of Alcohol 4%/Bupivicaine 0.5% solution. The recall was initiated due to a lack of assurance of sterility. The product is a prescription solution manufactured by Western Drug Inc. in Springerville, Arizona.
The affected product was distributed nationwide in the United States, specifically in Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah. The recall covers all lots of the product.
Consumers and healthcare providers should stop using the product and contact their healthcare provider or the recalling firm for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Alcohol4%/Bupivicaine0.5% sol, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938
- Manufacturer
- Western Drug
- Category
- Drug — Injectable Solution
- Affected units
- 3
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Part of a larger recall action
This product is one of 91 recalled by Western Drug under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 91 products in this recall →Related recalls
Same manufacturer · Western Drug
See all →- SevereWestern Drug Recalls Sodium Hydroxide 10% Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Benadryl Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls PZI 40 Insulin Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Ketorolac Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereZions RX Formulations Recalls Bupivacaine Due to Sterility Concerns
FDA (Drugs) · 2014-04-16
- SeverePharmakon Recalls Bupivacaine Bags Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SeverePharmedium Recalls Fentanyl and Bupivacaine Injections Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SeverePharmedium Recalls Bupivacaine HCl Injection Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SevereAbbott's Compounding Pharmacy Recalls Bupivacaine Due to Sterility Concerns
FDA (Drugs) · 2016-02-24
- SevereGreen Valley Drugs Recalls Bupivacaine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22